Breaking News, Collaborations & Alliances

UMass Chan, Caring Cross, Trenchant BioSystems Form Alliance to Develop Lower‑Cost Gene‑Therapy Manufacturing

Aim to create a scalable, place of care manufacturing platform that reduces facility requirements and lowers production costs.

Author Image

By: Charlie Sternberg

Associate Editor

The Department of Genetic & Cellular Medicine at UMass Chan Medical School, nonprofit Caring Cross, and manufacturing‑platform developer Trenchant BioSystems have formed a research alliance to develop a more accessible manufacturing process for autologous gene‑modified hematopoietic stem cell (HSC) therapies targeting sickle‑cell disease and beta‑thalassemia. The collaboration will combine UMass Chan’s expertise in blood stem‑cell biology, Caring Cross’s focus on expanding patient access ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters